Advancing tools to promote health equity across European Union regions: the EURO-HEALTHY project.


Journal

Health research policy and systems
ISSN: 1478-4505
Titre abrégé: Health Res Policy Syst
Pays: England
ID NLM: 101170481

Informations de publication

Date de publication:
13 Feb 2020
Historique:
received: 19 06 2019
accepted: 15 01 2020
entrez: 15 2 2020
pubmed: 15 2 2020
medline: 15 12 2020
Statut: epublish

Résumé

Population health measurements are recognised as appropriate tools to support public health monitoring. Yet, there is still a lack of tools that offer a basis for policy appraisal and for foreseeing impacts on health equity. In the context of persistent regional inequalities, it is critical to ascertain which regions are performing best, which factors might shape future health outcomes and where there is room for improvement. Under the EURO-HEALTHY project, tools combining the technical elements of multi-criteria value models and the social elements of participatory processes were developed to measure health in multiple dimensions and to inform policies. The flagship tool is the Population Health Index (PHI), a multidimensional measure that evaluates health from the lens of equity in health determinants and health outcomes, further divided into sub-indices. Foresight tools for policy analysis were also developed, namely: (1) scenarios of future patterns of population health in Europe in 2030, combining group elicitation with the Extreme-World method and (2) a multi-criteria evaluation framework informing policy appraisal (case study of Lisbon). Finally, a WebGIS was built to map and communicate the results to wider audiences. The Population Health Index was applied to all European Union (EU) regions, indicating which regions are lagging behind and where investments are most needed to close the health gap. Three scenarios for 2030 were produced - (1) the 'Failing Europe' scenario (worst case/increasing inequalities), (2) the 'Sustainable Prosperity' scenario (best case/decreasing inequalities) and (3) the 'Being Stuck' scenario (the EU and Member States maintain the status quo). Finally, the policy appraisal exercise conducted in Lisbon illustrates which policies have higher potential to improve health and how their feasibility can change according to different scenarios. The article makes a theoretical and practical contribution to the field of population health. Theoretically, it contributes to the conceptualisation of health in a broader sense by advancing a model able to integrate multiple aspects of health, including health outcomes and multisectoral determinants. Empirically, the model and tools are closely tied to what is measurable when using the EU context but offering opportunities to be upscaled to other settings.

Sections du résumé

BACKGROUND BACKGROUND
Population health measurements are recognised as appropriate tools to support public health monitoring. Yet, there is still a lack of tools that offer a basis for policy appraisal and for foreseeing impacts on health equity. In the context of persistent regional inequalities, it is critical to ascertain which regions are performing best, which factors might shape future health outcomes and where there is room for improvement.
METHODS METHODS
Under the EURO-HEALTHY project, tools combining the technical elements of multi-criteria value models and the social elements of participatory processes were developed to measure health in multiple dimensions and to inform policies. The flagship tool is the Population Health Index (PHI), a multidimensional measure that evaluates health from the lens of equity in health determinants and health outcomes, further divided into sub-indices. Foresight tools for policy analysis were also developed, namely: (1) scenarios of future patterns of population health in Europe in 2030, combining group elicitation with the Extreme-World method and (2) a multi-criteria evaluation framework informing policy appraisal (case study of Lisbon). Finally, a WebGIS was built to map and communicate the results to wider audiences.
RESULTS RESULTS
The Population Health Index was applied to all European Union (EU) regions, indicating which regions are lagging behind and where investments are most needed to close the health gap. Three scenarios for 2030 were produced - (1) the 'Failing Europe' scenario (worst case/increasing inequalities), (2) the 'Sustainable Prosperity' scenario (best case/decreasing inequalities) and (3) the 'Being Stuck' scenario (the EU and Member States maintain the status quo). Finally, the policy appraisal exercise conducted in Lisbon illustrates which policies have higher potential to improve health and how their feasibility can change according to different scenarios.
CONCLUSIONS CONCLUSIONS
The article makes a theoretical and practical contribution to the field of population health. Theoretically, it contributes to the conceptualisation of health in a broader sense by advancing a model able to integrate multiple aspects of health, including health outcomes and multisectoral determinants. Empirically, the model and tools are closely tied to what is measurable when using the EU context but offering opportunities to be upscaled to other settings.

Identifiants

pubmed: 32054540
doi: 10.1186/s12961-020-0526-y
pii: 10.1186/s12961-020-0526-y
pmc: PMC7020561
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

18

Subventions

Organisme : Medical Research Council
ID : MR/S019669/1
Pays : United Kingdom
Organisme : H2020 Health
ID : Grant Agreement No 643398

Investigateurs

Carlota Quintal (C)
João Malva (J)
Lúcio Cunha (L)
Paulo Nossa (P)
Ricardo Almendra (R)
Rui Gama Fernandes (RG)
Laia Palència (L)
Lluís Camprubí (L)
Maica Rodríguez-Sans (M)
Mercè Gotsens (M)
Sotiris Vardoulakis (S)
Clare Heaviside (C)
Quentin Tenailleau (Q)
Clara Squiban (C)
António Alvarenga (A)
Liliana Freitas (L)
Paulo Correia (P)
Céline Ledoux (C)
Eva Pilot (E)
Thomas Krafft (T)
Hynek Pikhart (H)
Joana Morrison (J)
Conrad Franke (C)
Bo Burström (B)
Evangelia Samoli (E)
Klea Katsouyanni (K)
Sophia Rodopoulou (S)
Dagmar Dzúrová (D)
Michala Lustigová (M)
Anna Cavallo (A)
Nathalie Coué (N)
Lucia Bosáková (L)
Michal Tkáč (M)
Hadewijch Vandenheede (H)
Patrick Deboosere (P)
Giuseppe Costa (G)
Nicolás Zengarini (N)

Références

Healthc Inform Res. 2012 Jun;18(2):88-96
pubmed: 22844644
Annu Rev Public Health. 2006;27:29-55
pubmed: 16533108
Soc Sci Med. 2000 Apr;50(7-8):915-21
pubmed: 10714916
Soc Sci Med. 1996 Mar;42(6):843-55
pubmed: 8778997
Lancet. 2012 Sep 15;380(9846):1011-29
pubmed: 22964159
Transl Behav Med. 2017 Sep;7(3):486-491
pubmed: 28397159
J Urban Health. 2013 Oct;90 Suppl 1:52-61
pubmed: 22527812
Health Promot Int. 2014 Jun;29 Suppl 1:i130-42
pubmed: 25217350
Popul Health Metr. 2003 Apr 14;1(1):6
pubmed: 12773210
Am J Public Health. 2014 Sep;104 Suppl 4:S517-9
pubmed: 25100411
Int J Environ Res Public Health. 2019 Mar 07;16(5):
pubmed: 30866549
Int J Health Serv. 1992;22(3):429-45
pubmed: 1644507
Int J Equity Health. 2019 Jun 25;18(1):100
pubmed: 31238946
Milbank Q. 2007;85(1):139-61
pubmed: 17319809
BMC Public Health. 2018 Apr 27;18(1):557
pubmed: 29703176
Popul Health Metr. 2019 Aug 7;17(1):11
pubmed: 31391120
J Health Popul Nutr. 2003 Sep;21(3):181-92
pubmed: 14717564
Am J Public Health. 2003 Mar;93(3):383-8
pubmed: 12604477
Lancet. 2005 Mar 19-25;365(9464):1099-104
pubmed: 15781105
Am Behav Sci. 2013 Aug;57(8):
pubmed: 24187340
Acta Inform Med. 2014 Dec;22(6):402-5
pubmed: 25684850
Soc Sci Med. 2015 Sep;141:100-8
pubmed: 26259012
Health Serv Insights. 2013 Nov 19;6:111-6
pubmed: 25114567
Eur J Health Econ. 2016 Jul;17(6):693-709
pubmed: 26280132
Prev Chronic Dis. 2010 Jul;7(4):A68
pubmed: 20550826
Public Health Rep. 2014 Jan-Feb;129 Suppl 2:5-8
pubmed: 24385658
Am J Public Health. 2003 Mar;93(3):380-3
pubmed: 12604476

Auteurs

Paula Santana (P)

Department of Geography and Tourism, Faculty of Arts and Humanities, University of Coimbra, Colégio S. Jerónimo, Largo D. Dinis, 3001-401, Coimbra, Portugal. paulasantana.coimbra@gmail.com.
CEGOT-UC, Centre of Studies in Geography and Territorial Planning, University of Coimbra, Coimbra, Portugal. paulasantana.coimbra@gmail.com.

Ângela Freitas (Â)

CEGOT-UC, Centre of Studies in Geography and Territorial Planning, University of Coimbra, Coimbra, Portugal.

Iwa Stefanik (I)

CEGOT-UC, Centre of Studies in Geography and Territorial Planning, University of Coimbra, Coimbra, Portugal.

Cláudia Costa (C)

CEGOT-UC, Centre of Studies in Geography and Territorial Planning, University of Coimbra, Coimbra, Portugal.

Mónica Oliveira (M)

CEG-IST, Centre for Management Studies of Instituto Superior Técnico, Universidade de Lisboa, Avenida Rovisco Pais, 1049-001, Lisbon, Portugal.

Teresa C Rodrigues (TC)

CEG-IST, Centre for Management Studies of Instituto Superior Técnico, Universidade de Lisboa, Avenida Rovisco Pais, 1049-001, Lisbon, Portugal.

Ana Vieira (A)

CEG-IST, Centre for Management Studies of Instituto Superior Técnico, Universidade de Lisboa, Avenida Rovisco Pais, 1049-001, Lisbon, Portugal.

Pedro Lopes Ferreira (PL)

CEISUC, Center for Health Studies and Research, Faculty of Economics, University of Coimbra, Coimbra, Portugal.

Carme Borrell (C)

ASPB, Agència de Salut Pública de Barcelona, Barcelona, Spain.
CIBER Epidemiología y Salud Pública (CIBERESP), Madrid, Spain.
Institut d'Investigació Biomèdica (IIB Sant Pau), Barcelona, Spain.

Sani Dimitroulopoulou (S)

PHE-CRCE, Centre for Radiation, Chemical and Environmental Hazards, Public Health England, Didcot, OX11 0RQ, United Kingdom.

Stéphane Rican (S)

LAboratoire DYnamiques Sociales et Recomposition des espaceS (LADYSS), Paris Nanterre University, Paris, France.

Christina Mitsakou (C)

PHE-CRCE, Centre for Radiation, Chemical and Environmental Hazards, Public Health England, Didcot, OX11 0RQ, United Kingdom.

Marc Marí-Dell'Olmo (M)

ASPB, Agència de Salut Pública de Barcelona, Barcelona, Spain.
CIBER Epidemiología y Salud Pública (CIBERESP), Madrid, Spain.
Institut d'Investigació Biomèdica (IIB Sant Pau), Barcelona, Spain.

Jürgen Schweikart (J)

Beuth University of Applied Sciences Berlin (BHT), Berlin, Germany.

Diana Corman (D)

Karolinska Institute (KI), Stockholm, Sweden.

Carlos A Bana E Costa (CA)

CEG-IST, Centre for Management Studies of Instituto Superior Técnico, Universidade de Lisboa, Avenida Rovisco Pais, 1049-001, Lisbon, Portugal.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH